Search

everythinglearnresearchcommunity

for

Search:↓

Ice cooling and vibration can reduce pain during PRP scalp injections without affecting treatment effectiveness.

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scalp cooling significantly reduces chemotherapy-induced hair loss.

No treatment fully prevents hair loss from chemotherapy yet.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Some cancer treatments can cause permanent hair loss.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The document says that there are treatments for hair and nail diseases.

Mild oxidative stress can prevent hair loss from chemotherapy.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Scalp cooling and minoxidil can help manage hair loss in children with cancer, but more research is needed.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.